mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.1 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.1 |
mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.1 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.1 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.1 |